SCHEMBL25798448

SCHEMBL25798448

COOc1ccc(C)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.45
▸ SMN1; SMN2 Q16637 5/20 0.43
▸ LMNA P02545 2/20 0.43
▸ DRD2 P14416 1/20 0.41
▸ DRD4 P21917 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ KCNH2 Q12809 2/20 0.41
▸ HTR2A P28223 1/20 0.41
▸ SLC6A4 P31645 1/20 0.41
▸ HPGD P15428 2/20 0.38
▸ MAPT P10636 8/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ POLB P06746 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ RAPGEF4 Q8WZA2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2205828 0.82 MAPT (0.50) CYP3A4SMN1; SMN2LMNADRD2DRD4
SCHEMBL14396803 0.79 HTR2A (0.51) CYP3A4SMN1; SMN2LMNADRD2DRD4
SCHEMBL3755105 0.76 CYP3A4 (0.46) CYP3A4SMN1; SMN2LMNADRD2DRD4
SCHEMBL27847863 0.75 ACHE (0.40) CYP3A4SMN1; SMN2LMNAKCNH2HPGD
SCHEMBL177455 0.74 CYP3A4 (0.45) CYP3A4SMN1; SMN2LMNADRD2DRD4
SCHEMBL14649910 0.74 HSP90AA1 (0.57) CYP3A4DRD2DRD4DRD3KCNH2
SCHEMBL4500324 0.74 DRD2 (0.49) CYP3A4SMN1; SMN2LMNADRD2DRD4
SCHEMBL675954 0.72 HTR2A (0.54) CYP3A4SMN1; SMN2DRD2DRD4DRD3
SCHEMBL6301020 0.72 NQO1 (0.52) CYP3A4DRD2DRD4DRD3KCNH2
SCHEMBL8736417 0.72 TEAD4 (0.48) CYP3A4SMN1; SMN2DRD2DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3894402-B1 N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2023-07-05 — — EP disclosed
Send feedback